Company news

MedCap AB news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

MedCap Signs Agreement To Acquire Biopsafe In Denmark

June 26, 2026

MedCap Completes Buyback Program

May 20, 2026

MCAP: Q1 2026 delivered double-digit revenue and profit growth, driven by strong segment performance

April 29, 2026

MedCap (Q4 review): Beat on Solid Organic Growth

February 11, 2026

MCAP: Record sales and EBITA growth in 2025, supported by strong operations and acquisitions

February 6, 2026

MCAP: Life science group achieves robust growth via acquisitions and innovation in core business areas

January 8, 2026

MCAP: Q3 2025 delivered 21% sales growth, 32% EBITA growth, and strong segment performance

October 24, 2025

Abilia Acquires Livassured

October 1, 2025

MCAP: Q2 2025 delivered double-digit sales and EBITA growth, with strong M&A momentum

July 23, 2025

MedCap's Business Area Specialty Pharma Completes the Acquisition of XGX Pharma

July 21, 2025

MedCap's Business Area Specialty Pharma Acquires XGX Pharma

June 25, 2025

MCAP: Q1 2025 delivered 7% sales growth, 17% EBITA margin, and strong M&A prospects

April 29, 2025

MCAP: Achieved SEK 1,807 million revenue in 2024 with a 23% EBITA CAGR, driven by acquisitions

March 10, 2025

MCAP: Q4 sales up 4%, but EBITA down 27% as Specialty Pharma faces royalty and pricing headwinds

January 31, 2025

MCAP: Strong growth in life science through buy & build, with 19% sales and 29% EBITA CAGR

November 14, 2024

MCAP: Q3 2024 delivered double-digit sales growth, led by Assistive Tech and MedTech strength

October 25, 2024

MCAP: Q2 sales up 19% and EBITA up 13%, with robust growth in Assistive Tech and MedTech

July 24, 2024

Decks

The 5 newest of 23 decks. Every deck is listed under its year.